Corkill M, Knapp D, Martin J, Hutchinson M L
Colorado Pathology Consultants, PC, Wheat Ridge, USA.
Acta Cytol. 1997 Jan-Feb;41(1):39-44. doi: 10.1159/000332303.
To assess specimen adequacy of the ThinPrep slide preparation method in routine use.
Two studies, a feasibility study of 299 women and a clinical study of 499 women, were conducted. A broom-type collection device was used and rinsed directly into Pre-servCyt vials. Slides were prepared with the ThinPrep 2000 device, screened and classified according to the Bethesda System. The proportion of ThinPrep slides described as "Satisfactory But Limited By: No Endocervical Component (SBLB:No ECC)" was then compared to the proportion of SBLB: No ECC slides found on conventional smears in a previously conducted clinical trial of over 7,000 patients.
For the feasibility study the proportion of ThinPrep slides described as SBLB: No ECC was 9.36% as compared to the clinical trial combined rate of 9.4% for conventional smears. For the clinical study, 4.96% of ThinPrep slides were SBLB:No ECC as compared to the 4.4% SBLB:No ECC rate for conventional smears from the same clinical trial. The proportions were statistically equivalent for both studies.
It is expected that the rate of representing endocervical component will be maintained when the ThinPrep preparation method is used routinely in place of the conventional cytologic smear method.
评估常规使用的ThinPrep玻片制备方法的标本充足性。
进行了两项研究,一项对299名女性的可行性研究和一项对499名女性的临床研究。使用扫帚型采集装置并直接冲洗到PreservCyt小瓶中。用ThinPrep 2000装置制备玻片,根据贝塞斯达系统进行筛查和分类。然后将描述为“满意但受限于:无宫颈管成分(SBLB:无ECC)”的ThinPrep玻片比例与先前一项超过7000名患者的临床试验中传统涂片上发现的SBLB:无ECC玻片比例进行比较。
在可行性研究中,描述为SBLB:无ECC的ThinPrep玻片比例为9.36%,而传统涂片的临床试验综合比例为9.4%。在临床研究中,4.96%的ThinPrep玻片为SBLB:无ECC,而同一临床试验中传统涂片的SBLB:无ECC比例为4.4%。两项研究的比例在统计学上相当。
预计当常规使用ThinPrep制备方法代替传统细胞学涂片方法时,宫颈管成分的显示率将得以维持。